Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates.
It has been proposed that certain adverse early experiences may play a role in determining subsequent susceptibility to adult anxiety and affective disorders and this relationship may be the result of altered neurodevelopment of the noradrenergic and/or serotonergic systems. In this study of nonhuman primates, the predictability of foraging requirements for mothers during an early period of their infants' lives was manipulated. When the offspring were young adults, these early manipulations were related to differences in behavioral response to acute administration of two putative anxiety-provoking agents: the noradrenergic probe, yohimbine, and the serotonergic probe, mCPP. These long-term effects of the developmental environment on subsequent pharmacological responsivity suggest that both neuronal systems may be permanently altered by early experiential factors.
Rosenblum
L A
LA
Department of Psychiatry, SUNY/Health Science Center at Brooklyn.
Coplan
J D
JD
Friedman
S
S
Bassoff
T
T
Gorman
J M
JM
Andrews
M W
MW
D000818:Animals; D000831:Animals, Newborn / Q000523:psychology; D001522:Behavior, Animal / Q000187:drug effects; D005247:Feeding Behavior / Q000187:drug effects; D008124:Locomotion / Q000187:drug effects; D008255:Macaca radiata / Q000523:psychology*; D008297:Male; D009638:Norepinephrine / Q000378:metabolism*; D016584:Panic Disorder / Q000139:chemically induced; D010865:Pilot Projects; D010879:Piperazines / Q000494:pharmacology*; D010919:Placebos; D012701:Serotonin / Q000378:metabolism*; D015016:Yohimbine / Q000494:pharmacology*
D010879:Piperazines; D010919:Placebos; D015016:Yohimbine; D012701:Serotonin; C015068:1-(3-chlorophenyl)piperazine; D009638:Norepinephrine